British Columbia Adds Three Anti-Clotting Biosimilars To PharmaCare
The Enoxaparin Biosimilars Include Redesca, Noromby And Inclunox
British Columbia has added three new biosimilar versions of the anti-clotting drug enoxaparin to PharmaCare, including Redesca, Noromby and Inclunox. The move comes after the Canadian province recently included additional biosimilars in its switching program.
